The Directorate of Government Examinations on Monday announced that the language exam for Class 12 students of the State Board would be postponed from May 3 to May 31.Students were scheduled to begin
Four associates of Belarusian opposition leader Svyatlana Tsikhanouskaya have pleaded not guilty to charges of organizing protests against authoritarian ruler Alyaksandr Lukashenka as their trial started on April 12 in the southeastern city of Homel.
Waverley Council is proud to announce that nominations are now open for the Mark & Evette Moran Nib Literary Award. The Nib Award is Waverley Council's.
(2) PRESS RELEASE
Immunocore presents phase 3 data comparing tebentafusp with investigator s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting
Tebentafusp is the first investigational therapy to improve Overall Survival (OS) in patients with metastatic uveal melanoma
First positive Phase 3 clinical trial for any T cell receptor therapeutic and first for any bispecific in a solid tumor
(Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, presented data from a phase 3 randomized trial comparing tebentafusp (IMCgp100) with investigator s choice in first-line metastatic uveal melanoma (mUM) in the clinical trial plenary session at the American Association for Cancer Research (AACR) Annual Meeting 2021.